Oxalieva 100mg

Oxalieva 100mg Injection is classified as a platinum-based antineoplastic agent. Its active component is Oxaliplatin. This medication is indicated for the treatment of stage 3 colon cancer following the surgical removal of the primary tumor, as well as metastatic cancer of the colon and rectum. It is typically administered alongside other anti-cancer therapies. Colorectal cancer primarily arises in the rectum and large intestine, stemming from a buildup of various genetic mutations. Both genetic and environmental factors significantly contribute to the development of colorectal cancer. This medication is effective against tumors that do not respond to cisplatin treatment.

Common side effects associated with Oxalieva 100mg Injection may include a decrease in blood cell count, a sensation of discomfort in the throat, diarrhea, nausea, vomiting, indigestion, heartburn, blood clots, hematuria (blood in urine), hypertension, depression, insomnia, and low calcium levels. It is important to notify your doctor if these side effects are bothersome or persist.

If you have a known allergy to Oxaliplatin or any of its components, inform your doctor. Prior to commencing treatment with this medication, disclose any history of moderate or mild kidney issues, liver conditions, or heart disorders to your physician. Additionally, inform your doctor about all medications you are currently taking, including any vaccinations. This medication is not advised for use in pregnant or breastfeeding women.